Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06758427Not Yet Recruiting

Hierarchy of Effects of Laboratory Markers and Their Interaction With Comorbidity Concerning Outcome and Personalized Treatment of Trauma Patients in Emergency Care and Rehabilitation

Role: collaborator

NCT03329326Completed

Comparison of Prosthetic Assessment Tools and Factors Influencing the Outcome

Role: collaborator

NCT02691650Completed

Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma

Role: collaborator

NCT02291900Not ApplicableUnknown

Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression

Role: lead

NCT02289976Not ApplicableUnknown

Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression

Role: lead

NCT00176163Phase 2Completed

Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain

Role: collaborator

All 6 trials loaded